Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xolani H Makhoba"'
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 12, Pp 10225-10247 (2023)
The non-structural protein 2 (NSP2) is an RNA-binding protein involved in coronavirus genome replication, and it often decreases human immune response to promote viral invasion and development. It is believed that the NSP2 associates itself with poly
Externí odkaz:
https://doaj.org/article/e7df205e6b334d52bf0d1378d9dbea72
Publikováno v:
Viruses, Vol 16, Iss 11, p 1726 (2024)
The SARS-CoV-2 spike protein is pivotal in the COVID-19 virus’s life cycle, facilitating viral attachment to host cells. It is believed that targeting this viral protein could be key to developing effective COVID-19 prophylactics. Using in silico t
Externí odkaz:
https://doaj.org/article/783f7a93bd23430588d4a10e5196d53f
Publikováno v:
Molecules, Vol 28, Iss 4, p 1686 (2023)
Environmental stimuli can distress the internal reaction of cells and their normal function. To react promptly to sudden environmental changes, a cascade of heat shock proteins (Hsps) functions to protect and act as housekeepers inside the cells. In
Externí odkaz:
https://doaj.org/article/95db6e6d9fbd44ecb92984d9d0028641
Autor:
Godlo Sesethu, Maxam Nombalentle, Mthembu Yamnkela, Mpumza Anelisa, Stanley Makumire, Noxolo Mkwetshana, Krishna K Govender, Xolani H Makhoba
The current drugs available in the market are not effective due to growing numbers of resistance to the causative agent of malaria. There are variousPlasmodiumparasites, of whichPlasmodium falciparumis the main cause of morbidity and mortality report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d0df83a0ade7fc5a11ac6059171c808
https://doi.org/10.1101/2023.05.11.540332
https://doi.org/10.1101/2023.05.11.540332
Publikováno v:
Drug Design, Development and Therapy
It is essential to acknowledge the efforts made thus far to manage or eliminate various disease burden faced by humankind. However, the rising global trends of the so-called incurable diseases continue to put pressure on Pharma industries and other d